TMune Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Buyout/​LBO
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 2

TMune Therapeutics General Information

Description

Developer of T cell therapies designed to treat cancer. The company's T cell therapies help in the treatment of cancer, lymphoma, HIV, and other infectious diseases, enabling patients to get cured and lead healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 2119 Delancey Street
  • Philadelphia, PA 19103
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TMune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO 03-Jan-2012 $1.5M 00.00 Completed Startup
2. Grant 01-Jan-2009 Completed Startup
1. Early Stage VC (Series A) 29-Feb-2008 Completed Startup
To view TMune Therapeutics’s complete valuation and funding history, request access »

TMune Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Louis Berneman Co-Founder, Principal, Chief Executive Officer, Director and Co-President
Dean Reid Executive, Strategic Accounts & Board Member
Douglas Lind MD Co-President & Board of Director
Carl June MD Scientific Co-Founder & Scientific Advisory Board Member
To view TMune Therapeutics’s complete executive team members history, request access »

TMune Therapeutics Board Members (4)

Name Representing Role Since
Carl June MD Self Scientific Co-Founder & Scientific Advisory Board Member 000 0000
David Wetherell Biomark Capital Board Member 000 0000
Dean Reid TMune Therapeutics Executive, Strategic Accounts & Board Member 000 0000
Joydeep Goswami Ph.D Self Board Member 000 0000
To view TMune Therapeutics’s complete board members history, request access »

TMune Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biomark Capital PE/Buyout Majority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view TMune Therapeutics’s complete investors history, request access »